Internal Medicine, Cardiovascular Disease · Dothan, AL
NPI
1326027491
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1150 Ross Clark Cir
Dothan, AL, 36301
Phone (334) 712-1929
Groups this clinician bills Medicare through
Medicare paid, 2024
$397K
8,136 services
Medicare patients, 2024
1,696
Average age 75
Drug cost, 2024
$1.9M
9,454 prescriptions
Company payments, 2025
$6,030
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andreas Muench was code 99490 (chronic, principal, and transitional care management), 1,204 times for 248 patients. In total Andreas Muench billed 8,136 services in 83 codes, and Medicare paid $397K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,204 | 248 | $45.90 | $55K |
| 93000 Electrocardiogram | Office | 1,138 | 735 | $9.05 | $10K |
| 93010 Electrocardiogram | Facility | 1,053 | 535 | $5.95 | $6,261 |
| 99214 Office E&M - Established | Office | 858 | 550 | $77.72 | $67K |
| 93306 Echocardiography (TTE/TEE) | Office | 397 | 387 | $117.45 | $47K |
| 93306 Echocardiography (TTE/TEE) | Facility | 315 | 292 | $48.21 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 298 | 139 | $57.48 | $17K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 276 | 69 | $7.63 | $2,107 |
| 93296 External Electrocardiographic Monitoring | Office | 255 | 112 | $12.33 | $3,144 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 208 | 105 | $87.50 | $18K |
| 93298 External Electrocardiographic Monitoring | Office | 196 | 36 | $56.48 | $11K |
| 93294 External Electrocardiographic Monitoring | Office | 181 | 76 | $17.48 | $3,164 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 138 | 88 | $33.60 | $4,636 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 138 | 137 | $120.14 | $17K |
| 99213 Office E&M - Established | Office | 133 | 120 | $57.41 | $7,635 |
By year: 2022 $592K for 9,415 services; 2023 $655K for 11,022 services; 2024 $397K for 8,136 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 50 | 47 | $8.65 | $433 |
| 83880 Clinical Chemistry | 47 | 47 | $38.47 | $1,808 |
Medicare prescription drug claims, 2024
In 2024, the drug Andreas Muench prescribed most often to Medicare patients was Amlodipine Besylate, with 680 prescriptions and refills. In total Andreas Muench wrote 9,454 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 680 | 1,758 | 243 | $3,592 |
| Eliquis Apixaban | 649 | 1,142 | 159 | $654K |
| Atorvastatin Calcium Generic | 647 | 1,767 | 204 | $6,759 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 526 | 1,246 | 183 | $6,934 |
| Metoprolol Tartrate Generic | 500 | 1,271 | 160 | $3,296 |
| Carvedilol Generic | 499 | 1,269 | 163 | $3,821 |
| Metoprolol Succinate Generic | 427 | 1,083 | 151 | $6,740 |
| Entresto Sacubitril/Valsartan | 416 | 753 | 103 | $496K |
| Furosemide Generic | 408 | 972 | 152 | $2,059 |
| Clopidogrel Clopidogrel Bisulfate | 319 | 774 | 110 | $4,003 |
| Potassium Chloride Generic | 250 | 555 | 85 | $3,335 |
| Losartan Potassium Generic | 238 | 624 | 87 | $1,795 |
| Xarelto Rivaroxaban | 230 | 439 | 57 | $240K |
| Nitroglycerin Generic | 196 | 216 | 97 | $2,289 |
| Ranolazine Er Ranolazine | 183 | 386 | 57 | $17K |
Brand drugs: 1,795 claims; generic drugs: 7,659 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andreas Muench $6,030 ($2,153 in general payments such as food, travel and fees and $3,878 for research) from 22 companies. The largest payer was Eli Lilly and Company with $3,878.
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company LLY | 1 | $3,878 |
| Medtronic, Inc. MDT | 14 | $902 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 17 | $227 |
| Abiomed JNJ | 2 | $206 |
| Shockwave Medical, Inc JNJ | 2 | $153 |
| Pfizer Inc. PFE | 5 | $92.46 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $77.55 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $71.97 |
| Merck Sharp & Dohme LLC MRK | 4 | $60.74 |
| Boston Scientific Corporation BSX | 1 | $56.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.